update deskIsrael News

Trump pardons Israeli man from 20-year sentence for drug offenses

It comes after the five children of Ronen Nahman, 41, wrote letters requesting a presidential pardon and also due to the health of his wife, Ruth, who suffers from terminal cancer.

U.S. President Donald Trump signing legislation in the Oval Office, January 2018. Source: White House.
U.S. President Donald Trump signing legislation in the Oval Office, January 2018. Source: White House.

U.S. President Donald Trump commuted the 20-year prison sentence on Monday of Israel-born Ronen Nahmani, who was convicted in 2015 of distributing synthetic drugs that he purchased from suppliers in China.

The 41-year-old Torah-observant Jew has already served four years in prison.

The pardon comes after Nahmani’s children wrote letters requesting a presidential pardon and also due to the health of his wife, Ruth, who suffers from terminal cancer.

“Mr. Nahmani is a non-violent, first-time offender with no criminal history. He has five young children at home, and his wife is suffering from terminal cancer. These extenuating circumstances underscore the urgency of his request for clemency,” the White House said in a statement.

It also noted that “members of Congress and a broad cross-section of the legal community have expressed support for clemency for Mr. Nahmani.”

“I’m still trying to catch my breath because I’m so overwhelmed; I can’t believe what happened, and I’m so grateful,” Ruth, told Hamodia news. “I don’t even have words in the dictionary to describe how grateful I am, how blessed I feel and how I overwhelmed I am with the joy in my heart.”

Among the lawyers fighting for Nahmani’s pardon was professor emeritus at Harvard Law School Alan Dershowitz, who said, “what President Trump did was the right thing; he ought to be praised for saving lives and doing a mitzvah. … I think it will be an important part of President Trump’s legacy that he did the right thing for the right reasons.”

You have read 3 articles this month.
Register to receive full access to JNS.

Just before you scroll on...

Israel is at war.

JNS is combating the stream of misinformation on Israel with real, honest and factual reporting. In order to deliver this in-depth, unbiased coverage of Israel and the Jewish world, we rely on readers like you.

The support you provide allows our journalists to deliver the truth, free from bias and hidden agendas. Can we count on your support?

Every contribution, big or small, helps JNS.org remain a trusted source of news you can rely on.

Become a part of our mission by donating today
Topics
Comments
Thank you. You are a loyal JNS Reader.
You have read more than 10 articles this month.
Please register for full access to continue reading and post comments.
Never miss a thing
Get the best stories faster with JNS breaking news updates